Brokerages expect ICON Public Limited (NASDAQ:ICLR) to report earnings per share (EPS) of $2.07 for the current quarter, according to Zacks Investment Research. Seven analysts have provided estimates for ICON Public’s earnings. The lowest EPS estimate is $2.00 and the highest is $2.13. ICON Public reported earnings of $1.20 per share during the same quarter last year, which indicates a positive year-over-year growth rate of 72.5%. The firm is expected to announce its next earnings results on Wednesday, July 28th.
On average, analysts expect that ICON Public will report full year earnings of $8.49 per share for the current financial year, with EPS estimates ranging from $8.25 to $8.64. For the next fiscal year, analysts forecast that the firm will report earnings of $9.22 per share, with EPS estimates ranging from $7.49 to $9.71. Zacks’ earnings per share calculations are an average based on a survey of analysts that follow ICON Public.
ICON Public (NASDAQ:ICLR) last issued its quarterly earnings results on Tuesday, April 27th. The medical research company reported $2.06 earnings per share for the quarter, beating the consensus estimate of $1.97 by $0.09. ICON Public had a return on equity of 21.42% and a net margin of 11.95%.
Several institutional investors and hedge funds have recently modified their holdings of ICLR. Amundi Pioneer Asset Management Inc. increased its position in shares of ICON Public by 2.1% during the first quarter. Amundi Pioneer Asset Management Inc. now owns 24,400 shares of the medical research company’s stock valued at $3,332,000 after acquiring an additional 500 shares during the last quarter. Sowell Financial Services LLC increased its position in shares of ICON Public by 74.7% during the fourth quarter. Sowell Financial Services LLC now owns 255 shares of the medical research company’s stock valued at $50,000 after acquiring an additional 109 shares during the last quarter. Fieldpoint Private Securities LLC increased its position in shares of ICON Public by 11.4% during the fourth quarter. Fieldpoint Private Securities LLC now owns 1,237 shares of the medical research company’s stock valued at $241,000 after acquiring an additional 127 shares during the last quarter. Kornitzer Capital Management Inc. KS increased its position in shares of ICON Public by 1.7% during the fourth quarter. Kornitzer Capital Management Inc. KS now owns 84,766 shares of the medical research company’s stock valued at $16,528,000 after acquiring an additional 1,400 shares during the last quarter. Finally, Todd Asset Management LLC increased its position in ICON Public by 18.6% in the fourth quarter. Todd Asset Management LLC now owns 103,487 shares of the medical research company’s stock worth $20,177,000 after buying an additional 16,225 shares during the last quarter. 81.70% of the stock is owned by institutional investors.
Shares of ICLR stock traded up $5.95 on Tuesday, hitting $219.44. The company had a trading volume of 753,301 shares, compared to its average volume of 575,832. The firm has a market cap of $11.77 billion, a P/E ratio of 35.58, a P/E/G ratio of 2.85 and a beta of 0.91. The stock’s 50-day moving average is $199.65 and its two-hundred day moving average is $197.70. ICON Public has a twelve month low of $145.11 and a twelve month high of $223.62.
ICON Public Company Profile
ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the strategic development, management and analysis of programs that support clinical development.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for ICON Public Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICON Public and related companies with MarketBeat.com's FREE daily email newsletter.